Preclinical GPS specializes in providing comprehensive preclinical development services tailored for biotech companies, ranging from virtual startups to mid-sized firms. Their offerings encompass a wide array of scientific services, including pharmacology, toxicology, and pharmacokinetics/ADME. The company conducts primary, secondary, and safety pharmacology studies to assess the efficacy and safety of drug candidates. Additionally, they assist clients in determining the appropriate toxicology studies to conduct, ensuring that the development process is both efficient and compliant with regulatory standards.

The firm also emphasizes the importance of customized pharmacokinetics (PK) and ADME (Absorption, Distribution, Metabolism, and Excretion) plans, which are tailored to the specific needs of each drug and program. Preclinical GPS provides project management services to streamline the execution of preclinical studies, ensuring that clients can focus on their core business operations. With a proven track record of over 1,400 completed studies, including multiple New Drug Applications (NDAs) and Investigational New Drug (IND) programs, Preclinical GPS positions itself as a leader in guiding biotech research and development.

United States

Designs and implements preclinical and CMC programs for virtual biotech to mid-sized pharmaceutical companies.

Bainbridge Island, Washington, United States

Preclinical GPS

Company Details